Dr. Meg Richards joined Panalgo with 30+ years' experience as an epidemiologist in both the private and public sectors. Private sector experience includes working at several CROs (PPD, ICON) and sponsors (Abbott Labs, now AbbVie and Genzyme, now Sanofi). Dr. Richards received her BS in nutrition from the University of New Hampshire and her MPH and PhD in epidemiology from the University of Illinois at Chicago.

Michael Munsell, PhD, is the Director of Real World Data HEOR at Norstella, specializing in study design, statistical methods, and the dissemination of real world evidence. He holds a PhD from Brandeis University, with a focus in computational economics, and an undergraduate degree in economics from the University of Michigan.

Kathryn Starzyk is an epidemiologist and VP of Real-World Evidence and Research Analytics at OM1. Previously, she was the Senior Director of Epidemiology and Outcomes Research at Outcome (now IQVIA), managing an international team of epidemiologists and outcome researchers, and driving the design and execution of over 50 patient registries globally. Prior to Outcome, she served as long-term lead for safety and risk management for products from clinical development through to post-marketing, with particular expertise in rare diseases, biologics and gene therapy applications at Genzyme (Sanofi). She has also held research positions at the Columbia School of Physicians and Surgeons and the National Institutes of Health’s Perinatal Research Branch, where her research focused on health disparities and maternal and fetal morbidity and mortality in the U.S. Kathryn is a graduate of Dartmouth College and the Harvard T.H. Chan School of Public Health.